Our leadership team, including recognized physician experts and researchers, is at the forefront of shaping new standards of cancer care based upon the latest research. Patients are at the heart of everything we do. Sarah Cannon offers integrated cancer services, providing patients with cutting-edge treatments and upholding the highest quality care for patients from diagnosis through survivorship.
Fred LeMaistre, MD
Senior Vice President, Sarah Cannon Market Operations and Physician-in-Chief of Blood Cancers
Dr. LeMaistre joined Sarah Cannon in 2012, and is responsible for the clinical operations of the Sarah Cannon markets and leads the development of the Sarah Cannon Blood Cancer Network which provides a multidisciplinary approach to standardize blood cancer therapies including blood and marrow transplantation (BMT). Previously the medical director for Texas Institute of Medicine and Surgery, LeMaistre is board certified in internal medicine and medical oncology, and has published more than 200 manuscripts.
He is a founding member and former president of the Foundation for the Accreditation of Cellular Therapy (FACT) and he established the first community-based BMT program in 1993. LeMaistre previously served as the president of the American Society for Blood and Bone Marrow Transplant and is currently a member of the American Society of Hematology. He received his medical degree from Southwestern Medical School in Texas and performed a fellowship in medical oncology at the University of Texas Health Science Center with training in BMT at Fred Hutchinson Cancer Center in Seattle, Wash.